Loading company…
Tierra Biosciences, based in San Leandro, California, runs a cell-free protein synthesis platform for custom proteins.
Founded in 2015 and based in California, US, Synvitrobio, Inc., doing business as Tierra Biosciences, develops cell-free manufacturing technology through automated data generation. Its Tierra Protein Platform makes custom purified proteins at microgram and milligram scale using machine learning and automation, for uses such as antibody engineering and synthetic biology. In March 2024 the company raised USD 11.4 million in Series A funding led by Material Impact Fund, with participation from Social Capital, Creative Ventures, Freeflow Ventures, Hillspire, In-Q-Tel and Prosus Ventures. CEO Michael Nemzek leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in